12/3
08:00 am
juns
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum
Medium
Report
Jupiter Neurosciences Marks Transformational First Year as a Public Company, Entering 2026 with Powerful Clinical and Commercial Momentum
12/2
07:07 pm
juns
Jupiter Neurosciences to Participate in NobleCon21 [Yahoo! Finance]
Low
Report
Jupiter Neurosciences to Participate in NobleCon21 [Yahoo! Finance]
11/5
08:30 am
juns
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
High
Report
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
10/27
08:30 am
juns
Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing
High
Report
Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing
9/15
08:39 am
juns
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador [Yahoo! Finance]
Low
Report
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador [Yahoo! Finance]
9/15
08:00 am
juns
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador
Medium
Report
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador